TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14960 · Jul 15

#csharp#cross_platform#csharp#vpn#xamarin VpnHood is a free, open-source VPN that helps you stay private online and access blocked content, even on networks with strict firewalls and deep packet inspection[1][5]. It works on Windows and Android, is easy to install, and runs fast without needing special network knowledge or admin rights[1]. You can choose which apps or countries use the VPN, and it supports both IPv4 and IPv6. Because it’s open source and has passed a security audit, you can trust that your data is safe and the software is transparent[1]. This means you get better privacy, can bypass restrictions, and have more control over your internet connection, all without cost or complexity[1][3]. https://github.com/vpnhood/VpnHood

Results

1 similar post found

Search: #floodbase

当前筛选 #floodbase清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 02/26/2025, 01:00 PM

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement